The biotech industry thrived during the pandemic, fueled by vaccine demand, but post-2022 saw capital declines. In 2024, capital increases reached €999 million, led by Qiagen...
Gilead said that it expects the agreement with Tentarix to reduce its earnings per share (EPS) from 3 to 4 cents in 2023. In addition, the...
Last March, the biopharmaceutical company Libera Bio signed a new collaboration agreement, after partnering with Immunoprecise Antibodies, a subsidiary of Talem Therapeutics, to discover multi-target antibodies...
Peaches Biotech is a company specializing in the creation of medicines based on advanced therapies, especially with cytokines, stem cells, or T-lymphocytes, which will allow patients...